Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2000
Operations: The Company operates 119 outpatient physical and occupational therapy clinics across 29 states. As of the reporting date, the average age of clinics was 3.72 years. The Company discontinued its surgery center initiative in March 2000 to focus exclusively on its therapy business.
Key Financial Metrics
| Metric (in thousands) | Q1 2000 | Q1 1999 |
|---|---|---|
| Net Revenues | $14,446 | $11,524 |
| Operating Income | $2,108 | $1,478 |
| Net Income | $671 | $461 |
| Diluted EPS | $0.19 | $0.13 |
| Operating Cash Flow | $1,669 | $557 |
| Cash and Equivalents (End of Period) | $4,397 | $6,276 |
| Total Debt (Notes Payable) | $8,084 | $8,084 |
| Current Ratio | 6.18:1 | N/A |
| Debt-to-Equity Ratio | 0.71:1 | N/A |
Note: Debt figures represent the aggregate principal of outstanding convertible subordinated notes ($3.05M + $2.0M + $3.0M). Current and debt-to-equity ratios are as of March 31, 2000, compared to December 31, 1999.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 25% ($2.89M) year-over-year. This was driven by 22 new clinics (contributing 42% of the increase) and a 13% increase in patient visits at existing clinics.
- Profitability: Net income rose 45% to $671,000. Operating margins improved as clinic operating costs as a percentage of revenue decreased from 76% to 73%.
- Expense Increases:
- Salaries: Increased 15% due to new clinic staffing and higher patient volume.
- Recruitment & Development: Increased 117% to $634,000. Approximately $301,000 of this increase was attributed to the now-discontinued surgery center initiative (severance, legal, and consulting fees).
- Bad Debt Provision: Increased 58% to $385,000, reflecting a rise in the provision rate from 2.2% to 2.7% of net patient revenues.
- Liquidity: Cash provided by operating activities more than tripled to $1.67M. However, cash balances decreased from the prior year due to capital expenditures ($803k) and distributions to minority investors ($517k).
Outlook, Risks, and Management Commentary
- Strategic Shift: Management discontinued the surgery center initiative in March 2000, citing an inability to secure targeted ownership by surgeon investors. The Company will now focus 100% on therapy clinic growth.
- Growth Targets: The Company aims to open 26 new clinics in 2000. Management expects initial operating losses from new clinics but anticipates favorable long-term impact based on historical performance.
- Regulatory Environment: The Medicare, Medicaid and SCHIP Balanced Budget Refinement Act of 1999 placed a two-year moratorium on the $1,500 reimbursement limit for therapy services, providing stability for 2000 and 2001.
- Accounting Changes: The Company is evaluating the impact of SAB 101 (Revenue Recognition), required for implementation in the quarter ended June 30, 2000. The impact is currently undetermined.
- Capital Structure: The Company has $8.05M in convertible subordinated notes outstanding. Management believes existing funds and operating cash flows are sufficient to meet current needs and development plans.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 13% increase in patient visits at existing clinics versus the contribution from new clinics.
- Bad Debt Trends: Monitor the rising provision for doubtful accounts (2.7% of revenue) to ensure it does not accelerate due to payer mix changes.
- Debt Conversion Risk: Assess the potential dilution from $8.05M in convertible notes with conversion prices ranging from $10.00 to $12.00 per share.
- Cost Management: Confirm that the $301,000 one-time cost related to the surgery center discontinuance does not recur and that recruitment costs stabilize.
- Regulatory Compliance: Watch for the impact of SAB 101 implementation on revenue recognition in the second quarter of 2000.